ROCHE 0245 ROCHE 0245
Generic Name: saquinavir
Pill imprint ROCHE 0245 ROCHE 0245 has been identified as Invirase 200 mg.
Invirase is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy.
Invirase 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Invirase Images
- Generic Name:
- saquinavir
- Imprint:
-
ROCHE 0245
ROCHE 0245 - Strength:
- 200 mg
- Color:
- Green / Yellow
- Size:
- 22.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose
microcrystalline cellulose
povidone k30
sodium starch glycolate type A potato
magnesium silicate
magnesium stearate
gelatin
water
ferric oxide red
ferric oxide yellow
ferrosoferric oxide
FD&C Blue No. 2
titanium dioxide
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Roche Laboratories
- National Drug Code (NDC):
- 00004-0245
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-3699 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Invirase resources
Search Again
